This inventor holds 5 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignee: University of California. Active years: 2019-2026.
Company Filing History:
Years Active: 2019-2026
Title: The Innovations of Laurent Vergnes
Introduction
Laurent Vergnes is a prominent inventor based in Los Angeles, CA. He has made significant contributions to the field of medical science, particularly in the development of compounds aimed at treating various health conditions. With a total of 5 patents to his name, Vergnes continues to push the boundaries of innovation.
Latest Patents
Among his latest patents are two notable inventions. The first is focused on glutarate compounds for treating ischemia-reperfusion injuries. This patent discloses methods for preventing, inhibiting, reducing, or treating ischemia and reperfusion injury to tissues using glutarate compounds such as α-ketoglutarate. The second patent involves ketobutyrate compounds and compositions for treating age-related symptoms and diseases. This invention outlines methods for treating, inhibiting, or reducing aging in subjects, as well as increasing their lifespan through the administration of ketobutyrate compounds.
Career Highlights
Laurent Vergnes is affiliated with the University of California, where he conducts his research and develops his innovative solutions. His work has garnered attention for its potential impact on health and longevity.
Collaborations
Some of his notable coworkers include Jing Huang and Xudong Fu, who contribute to the collaborative efforts in research and development within their field.
Conclusion
Laurent Vergnes exemplifies the spirit of innovation in medical research, with his patents paving the way for advancements in treatment options for ischemia and age-related conditions. His contributions are a testament to the importance of research and collaboration in the pursuit of better health solutions.